KVUE · 8-K · 20260806PR000141

Competition and Market Share

Kenvue Inc. · 2026-08-06 · Importance 17 · Surprise 24

Zyrtec® continued to gain share and strengthen its leadership position in U.S. Allergy. Pepcid® continued to outperform the Digestive Health market, while Nicorette® outperformed the Smoking Cessation category across major EMEA and Asia Pacific markets. Tylenol® consumption improved sequentially and the brand gained slight U.S. market share, while Kenvue reported share gains across major brands in Latin America.

Key facts

• Zyrtec continued to gain share and strengthen its leadership position in Allergy. source
• Nicorette outperformed the Smoking Cessation category across major markets. source